← Evidence map

ArticleJournal of gastroenterology2023

Serum AKR1B10 as an indicator of unfavorable survival of hepatocellular carcinoma.

Chenglin Xie et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37500927